Effects of Bright Light on Sleep Quality, Fatigue , and Mood Symptoms in Survivors With Gynecologic Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-20

Study Completion Date

2025-03-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: This study aimed to examine the efficacy of light therapy in improving sleep quality, reducing fatigue, and alleviating emotional symptoms among patients diagnosed with gynecologic cancer.

Methods: A randomized controlled trial was conducted at a medical center in northern Taiwan. Inclusion criteria included patients aged 18 years or older with a physician-confirmed diagnosis of gynecologic cancer and a score of ≥ 9 on the Chinese version of the Insomnia Severity Index (ISI-C). Eligible participants were randomly assigned to an experimental group or a control group (each with 47 subjects). At baseline (T0), all participants completed a demographic and treatment questionnaire, the ISI-C, the Taiwan version of the Brief Fatigue Inventory (BFI-T), and the Distress Thermometer (DT). The experimental group then underwent daily light therapy sessions via a circadian regulator for 30-40 minutes within 30 minutes of waking for four weeks. Meanwhile, the control group continued their usual routines during the same period. Follow-up assessments were conducted on days 7 (T1), 14 (T2), 21 (T3), and 28 (T4) post-intervention. Data was analyzed using SPSS 26.0, and generalized estimating equations (GEE) were employed to assess the effectiveness of light therapy.

Results: Generalized Estimating Equations (GEE) will be applied to examine group differences over time in sleep quality, fatigue, and emotional symptoms, in order to assess the effects of the intervention.

Conclusion: Light therapy is proposed as a potentially safe, low-risk, and cost-effective non-pharmacological intervention for improving sleep quality, reducing fatigue, and alleviating emotional distress in patients with gynecologic cancer following chemotherapy. This study is designed to evaluate the feasibility and potential effects of light therapy in this population, with the goal of informing future clinical applications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

NCT02954809

Fatigue Sleep Disturbance Circadian Dysregulation

COMPLETED NA

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

NCT03304587

Breast Cancer

COMPLETED NA

The Effects of Light Therapy to Treat Cancer-related Side Effects

NCT04418856

Breast Cancer Circadian Rhythms Fatigue +4 more

RECRUITING NA

Bright Light on Fatigue in Women Being Treated for Breast Cancer

NCT02658708

Breast Neoplasms Breast Cancer Cancer of Breast +1 more

COMPLETED PHASE1

The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer

NCT01193530

Advanced Cancers

TERMINATED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background and Rationale

Survivors of gynecologic cancers often experience persistent sleep disturbances, cancer-related fatigue, and emotional distress even after treatment has ended. These symptoms can significantly affect daily functioning, emotional well-being, and overall quality of life. Bright light therapy (BLT), a non-pharmacological intervention, has been shown in other populations to help regulate circadian rhythms and improve sleep and fatigue by suppressing melatonin levels. However, the application of BLT in gynecologic cancer survivors has not been well studied. This trial is designed to explore the potential of BLT in addressing these symptoms in this specific population.

Objectives

The primary objective is to evaluate the effects of a four-week bright light therapy intervention on sleep quality, fatigue, and emotional symptoms among gynecologic cancer survivors. It is hypothesized that participants receiving BLT will demonstrate improved outcomes in these domains compared to those receiving usual care.

Study Design

This is a randomized, controlled, single-blind trial with a parallel-group design. Eligible participants will be randomly assigned in a 1:1 ratio to either the intervention group (BLT) or the control group. Outcome assessors will remain blinded to group allocation throughout the study.

Intervention

Participants in the intervention group will receive bright light therapy using Re-Timer® light therapy glasses, which emit green-blue light at an intensity of 506 lux. Participants will be instructed to wear the glasses for 45 minutes each morning over four consecutive weeks. Sessions are self-administered at home between 7:00 AM and 9:00 AM, based on circadian rhythm guidance.

Control Condition

The control group will receive usual care and will not be provided with any light therapy. Participants in this group will be instructed to maintain their typical daily routines and avoid introducing new interventions that could impact sleep or mood during the study period.

Outcome Measures and Timepoints

Outcome data will be collected through an online questionnaire via the LINE messaging app at the following timepoints:

T1: Day 7 of intervention

T2: Day 14 of intervention

T3: Day 21 of intervention

T4: Day 28 of intervention

The following instruments will be used:

Insomnia Severity Index - Chinese version (ISI-C): to assess insomnia symptoms

Brief Fatigue Inventory - Taiwanese version (BFI-T): to assess cancer-related fatigue

Distress Thermometer (DT): to assess emotional distress

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gynecologic Cancer Survivors Sleep Quality Fatigue Mood Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomly assigned to either the bright light group or the dim red light control group in a parallel design. Each participant received only one type of light intervention throughout the study.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bright Light Intervention Group

Participants in this group received daily morning exposure to bright white light (506 lux) using the Re-Timer® light therapy glasses for 45 minutes per day, over a 4-week period.

Group Type EXPERIMENTAL

Re-Timer® light therapy glasses

Intervention Type DEVICE

Participants wore Re-Timer® glasses that emitted bright white light at 506 lux for 30 minutes each morning, over a 4-week intervention period.

Usual Care

Participants in this group received usual care and did not receive any light therapy intervention during the study period.

Group Type OTHER

Usual Care

Intervention Type OTHER

Participants received standard follow-up care with no light therapy intervention during the 4-week period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Re-Timer® light therapy glasses

Participants wore Re-Timer® glasses that emitted bright white light at 506 lux for 30 minutes each morning, over a 4-week intervention period.

Intervention Type DEVICE

Usual Care

Participants received standard follow-up care with no light therapy intervention during the 4-week period.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female participants aged 18 years or older.
2. Diagnosed with ovarian cancer, cervical cancer, fallopian tube cancer, or endometrial cancer, and have completed primary treatment (surgery, chemotherapy, or radiation) for more than 3 months, Currently in the treatment stage.
3. Insomnia Severity Index-Chinese Version (ISI-C) score ≥ 9, indicating clinical insomnia (Yang et al., 2009).
4. If currently using psychiatric medications, the dosage must have remained stable for at least 6 weeks prior to participation.
5. Able to speak Mandarin or Taiwanese fluently and read and write in Chinese.
6. Able to use a smartphone.
7. Conscious, capable of understanding the study procedures, willing to sign informed consent, and agree to participate.

Exclusion Criteria

1. History of psychiatric hospitalization or severe psychiatric disorders within the past 6 months.
2. Eye diseases or ophthalmologic surgery within the past two weeks, conditions contraindicating light therapy, or use of photosensitizing drugs (e.g., cataracts).
3. Currently taking hypnotic medications.
4. Habitual smoking or alcohol use.
5. Working night shifts, rotating shifts, or frequent travel across multiple time zones.
6. Currently pregnant.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No